Omega-3 fatty acids in obesity and metabolic syndrome: a mechanistic update
K Albracht-Schulte, NS Kalupahana… - The Journal of nutritional …, 2018 - Elsevier
Strategies to reduce obesity have become public health priorities as the prevalence of
obesity has risen in the United States and around the world. While the anti-inflammatory and …
obesity has risen in the United States and around the world. While the anti-inflammatory and …
Causes and consequences of hypertriglyceridemia
CJ Packard, J Boren, MR Taskinen - Frontiers in endocrinology, 2020 - frontiersin.org
Elevations in plasma triglyceride are the result of overproduction and impaired clearance of
triglyceride-rich lipoproteins—very low-density lipoproteins (VLDL) and chylomicrons …
triglyceride-rich lipoproteins—very low-density lipoproteins (VLDL) and chylomicrons …
Effect of the amount and type of dietary fat on cardiometabolic risk factors and risk of developing type 2 diabetes, cardiovascular diseases, and cancer: a systematic …
U Schwab, L Lauritzen, T Tholstrup… - Food & nutrition …, 2014 - Taylor & Francis
The effects of both the amount and quality of dietary fat have been studied intensively during
the past decades. Previously, low-fat diets were recommended without much attention to the …
the past decades. Previously, low-fat diets were recommended without much attention to the …
Omega-3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver disease
E Scorletti, CD Byrne - Annual review of nutrition, 2013 - annualreviews.org
Long-chain omega-3 fatty acids belong to a family of polyunsaturated fatty acids that are
known to have important beneficial effects on metabolism and inflammation. Such effects …
known to have important beneficial effects on metabolism and inflammation. Such effects …
[图书][B] Handbook of nutraceuticals and functional foods
REC Wildman, R Wildman, TC Wallace - 2016 - taylorfrancis.com
Scientific advances in this field have not only given us a better understanding of what is an
optimal diet, but has allowed food and nutraceutical companies to market products with …
optimal diet, but has allowed food and nutraceutical companies to market products with …
Fish oil—how does it reduce plasma triglycerides?
GC Shearer, OV Savinova, WS Harris - … BBA)-Molecular and Cell Biology of …, 2012 - Elsevier
Long chain omega-3 fatty acids (FAs) are effective for reducing plasma triglyceride (TG)
levels. At the pharmaceutical dose, 3.4 g/day, they reduce plasma TG by about 25–50% after …
levels. At the pharmaceutical dose, 3.4 g/day, they reduce plasma TG by about 25–50% after …
Current evidence supporting the link between dietary fatty acids and cardiovascular disease
Lack of consensus exists pertaining to the scientific evidence regarding effects of various
dietary fatty acids on cardiovascular disease (CVD) risk. The objective of this article is to …
dietary fatty acids on cardiovascular disease (CVD) risk. The objective of this article is to …
Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: the EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial
JJP Kastelein, KC Maki, A Susekov, M Ezhov… - Journal of clinical …, 2014 - Elsevier
Background Omega-3 fatty acids in free fatty acid form have enhanced bioavailability, and
plasma levels are less influenced by food than for ethyl ester forms. Objective The aim was …
plasma levels are less influenced by food than for ethyl ester forms. Objective The aim was …
[HTML][HTML] Safety of supplementation of omega-3 polyunsaturated fatty acids (PUFAs): a systematic review and meta-analysis of randomized controlled trials
Background There is no comprehensive review of the evidence to support omega-3
polyunsaturated fatty acids (PUFAs) as a relatively safe and tolerable intervention. Objective …
polyunsaturated fatty acids (PUFAs) as a relatively safe and tolerable intervention. Objective …
[HTML][HTML] Can N-3 polyunsaturated fatty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications?
AM Darwesh, W Bassiouni, DK Sosnowski… - Pharmacology & …, 2021 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19), caused by the Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2), has currently led to a global pandemic with …
Syndrome Coronavirus 2 (SARS-CoV-2), has currently led to a global pandemic with …